| 2922.50.17 | 00 | Dermatological agents and local anesthetics | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P,SG) | 15.4￠/kg + 51.5% |
| 2922.50.35 | 00 | Products described in additional U.S. note 3 to section VI | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P) 2.9% (SG) | 15.4￠/kg + 50% |
| 2923 | | Quaternary ammonium salts and hydroxides; lecithins and other phosphoaminolipids, whether or not chemically defined: | | | | |
| 2923.10.00 | 00 | Choline and its salts | kg | 3.7% | Free (A,AU,BH,CA, CL,E,IL,J,JO, K,MA,MX, P,SG) | 25% |
| 2923.20 | | Lecithins and other phosphoaminolipids: | | | | |
| 2923.20.10 | 00 | Purified egg phospholipids, pharmaceutical grade meeting requirements of the U.S. Food and Drug Administration, for use in intravenous fat emulsion | kg | Free | | 16.5￠/kg + 30% |
| 2924 | | Carboxyamide-function compounds; amide-function compounds of carbonic acid: | | | | |
| 2924.11.00 | 00 | Acyclic amides (including acyclic carbamates) and their derivatives; salts thereof: | | | | |
| 2924.11.00 | 00 | Meprobamate (INN) | kg | Free | | 25% |
| 2924.12.00 | 00 | Fluoroacetamide (ISO), monocrotophos (ISO) and phosphamidon (ISO) | kg | 3.7% | Free (A,AU,BH,CA, CL,E,IL,J,JO, K,MA,MX, P,SG) | 25% |
| 2924.21 | | Cyclic amides (including cyclic carbamates) and their derivatives; salts thereof: | | | | |
| 2924.21 | | Ureines and their derivatives; salts thereof: | | | | |
| 2924.21.04 | 00 | 3-(p-Chlorophenyl)-1,1-dimethylurea (Monuron) | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, MA,MX, P,SG) | 15.4￠/kg + 40.5% |
| 2924.21.08 | 00 | 1,1-Dimethyl-3-( α, α, α-trifluoro-￠/tolyl)urea (Fluometuron) | kg | Free | | 15.4￠/kg + 40.5% |
| 2924.21.12 | 00 | 1-(2-Methylcyclohexyl)-3-phenylurea | kg | Free | | 15.4￠/kg + 48.5% |
| 2924.21.18 | 00 | sym-Diethyldiphenylurea | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, MA,MX,P) 0.2￠/kg + 3.3% (SG) | 15.4￠/kg + 58% |
| 2924.21.20 | 00 | Products described in additional U.S. note 3 to section VI | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,L,MA,MX, P) 2.9% (SG) | 15.4￠/kg + 58% |
| 2924.23.10 | 00 | 2-Acetamidobenzoic acid (N-acetylanthranilic acid) and its salts: | | | | |
| 2924.23.10 | 00 | 2-Acetamidobenzoic acid | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,MA,MX,P) 0.2￠/kg + 3.3% (SG) | 15.4￠/kg + 58% |
| 2924.23.70 | 00 | Products described in additional U.S. note 3 to section VI | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,L,MA,MX, P) 2.9% (SG) | 15.4￠/kg + 58% |
| 2924.24.00 | 00 | Ethinamate (INN) | kg | Free | | 30.5% |
| 2924.29.01 | 00 | p-Acetanisidide; p-Acetoacetotoluidide; 4'-Amino-N-methylacetanilide; 2,5-Dimethoxyacetanilide; and N-(7-Hydroxy-1-naphthyl)acetamide | kg | Free | | 15.4￠/kg + 39.5% |
| 2924.29.03 | 00 | 3,5-Dinitro-o-toluamide | kg | Free | | 15.4￠/kg + 47.5% |
| 2924.29.05 | 00 | Biligrafin acid; 3,5-Diacetamido-2,4,6-triiodobenzoic acid; and Metrizoic acid | kg | 5.3% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P,SG) | 15.4￠/kg + 34% |
| 2924.29.10 | 00 | Acetanilide; N-Acetylsulfanilyl chloride; Aspartame; and 2-Methoxy-5-acetamino-N,N- bis(2-acetoxyethyl)aniline | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, K,MA,MX,P) 0.2￠/kg + 3.3% (SG) | 15.4￠/kg + 58% |
